These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3024919)

  • 1. EBV-activation of human B-lymphocytes.
    Aman P; Lewin N; Nordström M; Klein G
    Curr Top Microbiol Immunol; 1986; 132():266-71. PubMed ID: 3024919
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
    Ernberg I; Kallin B; Dillner J
    Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of TGF-beta on the proliferation of B cell lines and on the immortalisation of B cells by EBV.
    Altiok A; Bejarano MT; Klein E
    Curr Top Microbiol Immunol; 1990; 166():375-80. PubMed ID: 1963587
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of polyamine synthesis in human B lymphocytes during primary infection with Epstein-Barr virus (EBV) blocks cellular DNA synthesis but not the expression of EBV-encoded nuclear antigens (EBNA).
    Aman P; Oredsson SM; Heby O
    Biochem Biophys Res Commun; 1989 Mar; 159(3):945-52. PubMed ID: 2539156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of mouse lymphocytes by Epstein-Barr virus. II. Stimulation of cellular DNA synthesis by EBV in the absence of EBNA induction and cell transformation.
    Gross TG; Volsky DJ
    Virology; 1984 Feb; 133(1):211-5. PubMed ID: 6322431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Hammerschmidt W; Sugden B
    Nature; 1989 Aug; 340(6232):393-7. PubMed ID: 2547164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation.
    Moss DJ; Rickinson AB; Wallace LE; Epstein MA
    Nature; 1981 Jun; 291(5817):664-6. PubMed ID: 6264317
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG; Catovsky D; Crawford DH
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus terminal protein gene transcription is dependent on EBNA2 expression and provides evidence for viral integration into the host genome.
    Zimber-Strobl U; Suentzenich K; Falk M; Laux G; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
    Curr Top Microbiol Immunol; 1990; 166():359-66. PubMed ID: 1963585
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB
    Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment and characterization of EBNA-negative, EBV-genome DNA-positive B cell lines].
    Nakano M; Toyama K; Niizuma M; Hayata Y
    Nihon Ketsueki Gakkai Zasshi; 1988 May; 51(3):596-605. PubMed ID: 2844050
    [No Abstract]   [Full Text] [Related]  

  • 16. Regions of the EBV genome involved in latency and lymphocyte immortalization.
    Miller G
    Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
    [No Abstract]   [Full Text] [Related]  

  • 17. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
    Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr viral DNA: infectivity for human placental cells.
    Miller G; Grogan E; Heston L; Robinson J; Smith D
    Science; 1981 Apr; 212(4493):452-5. PubMed ID: 6259735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus induced differentiation of early B-lineage cells.
    Kubagawa H; Burrows PD; Grossi CE; Cooper MD
    Curr Top Microbiol Immunol; 1986; 132():246-50. PubMed ID: 3024917
    [No Abstract]   [Full Text] [Related]  

  • 20. Immortalization of human lymphocytes by Epstein-Barr virus.
    Miller G
    Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.